Seven of the most heavily shorted stocks on the Australian Securities Exchange have defied bearish sentiment, leaving hedge funds staring at approximately $1 billion in potential losses.

The group includes companies across pharmaceuticals, intellectual property, and data center operations, which have all posted gains despite significant short interest.

While hedge funds have increased their total short bets on Australian equities to $61 billion since the start of 2026, these specific names have refused to follow the broader downward pressure.

This divergence highlights a growing disconnect between aggregate short positioning and individual stock performance.

While hedge funds have increased their total short bets on Australian equities to $61 billion since the start of 2026, these specific names have refused to follow the broader downward pressure.

The concentration of losses in these seven stocks suggests that short sellers may be facing a squeeze or that their thesis on these specific companies is failing.

The Australian market has seen a surge in short selling activity this year, with funds betting against a wide range of sectors.